chevron_leftBack
As of 24 April 2025, Sichuan Biokin Pharmaceutical Co.,Ltd. has a market cap of $15.6B USD, ranking #1172 globally and #132 in China. It ranks #99 in the Healthcare sector, and #10 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$15.6BUSD
113.68B CNY
Enterprise Value
$15.44BUSD
112.53B CNY
Revenue (TTM)
$799.06MUSD
5.82B CNY
EBITDA (TTM)
$523.08MUSD
3.81B CNY
Net Income (TTM)
$508.78MUSD
3.71B CNY
EBITDA Margin
65%
Profit Margin
64%
PE Ratio
30.6
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yi Zhu
open_in_new
Employees
2,086
Founded
2006
Website
baili-pharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.8% | 12% | 36% | 48% | 49% | 138% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688506
四川百利天恒药业股份有限公司 Class A
ISIN: CNE100006FN4
Shares Out.:
Shares Outstanding:
90.451M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
283.50 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sichuan Biokin Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China.
